ScholarIQanswers from OpenAlex

Risk Factors and Racial and Ethnic Disparities in Patients With Breast Cancer–Related Lymphedema

PaperCitations, authors & open-access status

Risk Factors and Racial and Ethnic Disparities in Patients With Breast Cancer–Related Lymphedema is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Risk Factors and Racial and Ethnic Disparities in Patients With Breast Cancer–Related Lymphedema have?

ScholarIQcitation count

Risk Factors and Racial and Ethnic Disparities in Patients With Breast Cancer–Related Lymphedema has 106 citations in the OpenAlex counts ScholarIQ stores.

When was Risk Factors and Racial and Ethnic Disparities in Patients With Breast Cancer–Related Lymphedema published?

ScholarIQyear

Risk Factors and Racial and Ethnic Disparities in Patients With Breast Cancer–Related Lymphedema has 2022 year in the ScholarIQ index.

What is the open-access status of Risk Factors and Racial and Ethnic Disparities in Patients With Breast Cancer–Related Lymphedema?

ScholarIQoa status

Risk Factors and Racial and Ethnic Disparities in Patients With Breast Cancer–Related Lymphedema has bronze oa status in the ScholarIQ index.

What is the DOI of Risk Factors and Racial and Ethnic Disparities in Patients With Breast Cancer–Related Lymphedema?

ScholarIQdoi

The DOI for Risk Factors and Racial and Ethnic Disparities in Patients With Breast Cancer–Related Lymphedema is on the source record.

What is the PMID of Risk Factors and Racial and Ethnic Disparities in Patients With Breast Cancer–Related Lymphedema?

ScholarIQpmid

The PMID for Risk Factors and Racial and Ethnic Disparities in Patients With Breast Cancer–Related Lymphedema is on the source record.

What is the OpenAlex record for Risk Factors and Racial and Ethnic Disparities in Patients With Breast Cancer–Related Lymphedema?

ScholarIQopenalex

The OpenAlex for Risk Factors and Racial and Ethnic Disparities in Patients With Breast Cancer–Related Lymphedema is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial